Advertisement

FDA releases creative plan to improve access to nonprescription medications

  • Web Desk
  • Share

FDA

plan to improve access to nonprescription medications

Advertisement
  • Nonprescription drug treatments are in use by consumers without the supervision of a professional.
  • If finalised, the proposed rule would require drug companies to include an additional condition for nonprescription use.
  • This could mean proposing a set of questions on a self-selection test.
Advertisement

FDA releases creative plan to improve access to nonprescription medications. Consumers utilise non-prescription medication therapies; without the guidance of a medical expert (HCP). It is the responsibility of the patients receiving these therapies; to determine which medication is best for their condition; and to utilise it correctly.

Currently, nonprescription pharmacological therapies are not allow; to those that give consumers enough information; to properly choose and use the drug. When filing a new application to bring a nonprescription drug therapy to market; drug companies would have to include an extra criterion; for nonprescription usage if the proposed rule were to become law. FDA Commissioner Robert Califf commented on the proposed rule; saying: “Nonprescription medication items play a crucial role; in America’s healthcare system, since millions of Americans use them daily; to self-manage health concerns.

Also Read

FDA restricts who can receive Johnson & Johnson COVID-19 Vaccine

Regulators placed limits Thursday on who can receive Johnson & Johnson's COVID-19 vaccine, saying...

This proposal “may widen the sorts of pharmaceuticals; that can be approved as nonprescription; enhancing access of drugs that would otherwise only be available by prescription”; according to the FDA.

According to the proposed rule, an applicant may suggest an additional requirement; for nonprescription use that a consumer must successfully meet in order to obtain the product if the FDA determines; that “Drug Facts Labelling” is insufficient as the primary source; for a nonprescription drug treatment to ensure appropriate self-selection; and use by consumers.

A nonprescription drug treatment application must also put in place; one or more FDA-approved requirements that guarantee appropriate self-selection; appropriate actual usage, or both; on the part of nonprescription drug treatment users.

Advertisement

Also Read

Menthol and flavored cigarettes to be banned by FDA

Menthol and flavored cigarettes to be banned by FDA The Food and...

 

 

Advertisement
Read More News On

Catch all the Business News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Live News.


Advertisement
End of Story
BOL Stories of the day
Trump leads with 312 electoral votes, Harris trails at 226 in final tally
Trump’s White House comeback puts criminal cases on pause
World leaders congratulate Trump on election win
Here’s how the voting process works in US
Early voting returns may mislead US election results
Now is the time to end Gaza war; says US
Next Article
Exit mobile version